Cite
HARVARD Citation
Li, C. et al. (2019). A Proresolving Peptide Nanotherapy for Site‐Specific Treatment of Inflammatory Bowel Disease by Regulating Proinflammatory Microenvironment and Gut Microbiota. Advanced science. 6 (18), p. n/a. [Online].